| 000 | 01785 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513045013.0 | ||
| 264 | 0 | _c19950302 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1994.tb04370.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuchs, W | |
| 245 | 0 | 0 |
_aLansoprazole does not affect the bioavailability of oral contraceptives. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cOct 1994 |
||
| 300 |
_a376-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aContraceptives, Oral _xblood |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aEstradiol _xblood |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 |
_aGlucaric Acid _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xanalogs & derivatives |
| 650 | 0 | 4 | _aLansoprazole |
| 650 | 0 | 4 |
_aLevonorgestrel _xblood |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 | _aMenstrual Cycle |
| 650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
| 650 | 0 | 4 |
_aProgesterone _xblood |
| 650 | 0 | 4 | _aProton Pump Inhibitors |
| 650 | 0 | 4 |
_aSex Hormone-Binding Globulin _xmetabolism |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aSennewald, R | |
| 700 | 1 | _aKlotz, U | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 38 _gno. 4 _gp. 376-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1994.tb04370.x _zAvailable from publisher's website |
| 999 |
_c7832573 _d7832573 |
||